Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

P‐74 Evaluation of the in vivo effects of Tris‐EDTA and chlorhexidine digluconate 0.15% solution in chronic bacterial otitis externa: 11 cases

Identifieur interne : 001C79 ( Istex/Corpus ); précédent : 001C78; suivant : 001C80

P‐74 Evaluation of the in vivo effects of Tris‐EDTA and chlorhexidine digluconate 0.15% solution in chronic bacterial otitis externa: 11 cases

Auteurs : G. Ghibaudo ; L. Cornegliani ; P. Martino

Source :

RBID : ISTEX:3EC2FB89D7D040C56ADD942A27C23D367319F1DA

Abstract

The objectives of this study were to evaluate in vivo tolerance, and antimicrobial and clinical activities of a topical otic preparation containing EDTA tromethamine (Tris) and chlorhexidine digluconate 0.15% solution (Otodine®) in dogs with chronic bacterial otitis externa. Eleven dogs were included. The affected ears were filled with the solution once daily during a 2‐week period. Dogs were evaluated on days 0, 14 and 28. Three clinical parameters (exudate, erythema, pain) and three cytologic parameters (Malassezia, cocci, rods) were scored (0–4 scale) by otoscopic and cytological examinations of otic exudate. Bacterial cultures were performed at each time point. If there were bacteria on cytological examination on day 14, the dogs were treated with the original product, with the addition of enrofloxacin (5%) applied 10 min after the original product, for a further 2 weeks. All 11 cases yielded isolates of resistant gram‐negative bacteria; gram‐positive bacteria were also isolated from six of 11 dogs. On day 14, six of 11 dogs were negative on culture examination; on day 28, 10 of 11 were negative and only one case had a positive culture. On day 14, clinical and microbial scores (cytology) were reduced by 54.6 and 71.1%, respectively, and by 85.7 and 94% on day 28. All cases reported good tolerance of the treatment. The results show that this ear solution was helpful in the management of chronic bacterial otitis externa in dogs and was well tolerated. There seems to be a synergistic effect of the combination of Tris‐EDTA/chlorhexidine digluconate 0.15% solution, and an antimicrobial agent (enrofloxacin) against resistant gram‐positive and gram‐negative bacteria. Funding: Self‐funded.

Url:
DOI: 10.1111/j.1365-3164.2004.00414_74.x

Links to Exploration step

ISTEX:3EC2FB89D7D040C56ADD942A27C23D367319F1DA

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">P‐74 Evaluation of the in vivo effects of Tris‐EDTA and chlorhexidine digluconate 0.15% solution in chronic bacterial otitis externa: 11 cases</title>
<author>
<name sortKey="Ghibaudo, G" sort="Ghibaudo, G" uniqKey="Ghibaudo G" first="G." last="Ghibaudo">G. Ghibaudo</name>
<affiliation>
<mods:affiliation>Clinica Veterinaria Malpensa, Samarate (Varese), Italy; Ambulatorio Veterinario Associato, Torino, Italy; Facoltà di Medicina Veterinaria, Università Degli Studi di Milano, Milano, Italy</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cornegliani, L" sort="Cornegliani, L" uniqKey="Cornegliani L" first="L." last="Cornegliani">L. Cornegliani</name>
<affiliation>
<mods:affiliation>Clinica Veterinaria Malpensa, Samarate (Varese), Italy; Ambulatorio Veterinario Associato, Torino, Italy; Facoltà di Medicina Veterinaria, Università Degli Studi di Milano, Milano, Italy</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Martino, P" sort="Martino, P" uniqKey="Martino P" first="P." last="Martino">P. Martino</name>
<affiliation>
<mods:affiliation>Clinica Veterinaria Malpensa, Samarate (Varese), Italy; Ambulatorio Veterinario Associato, Torino, Italy; Facoltà di Medicina Veterinaria, Università Degli Studi di Milano, Milano, Italy</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:3EC2FB89D7D040C56ADD942A27C23D367319F1DA</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1111/j.1365-3164.2004.00414_74.x</idno>
<idno type="url">https://api.istex.fr/document/3EC2FB89D7D040C56ADD942A27C23D367319F1DA/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001C79</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001C79</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">P‐74 
Evaluation of the
<hi rend="italic">in vivo</hi>
effects of Tris‐EDTA and chlorhexidine digluconate 0.15% solution in chronic bacterial otitis externa: 11 cases</title>
<author>
<name sortKey="Ghibaudo, G" sort="Ghibaudo, G" uniqKey="Ghibaudo G" first="G." last="Ghibaudo">G. Ghibaudo</name>
<affiliation>
<mods:affiliation>Clinica Veterinaria Malpensa, Samarate (Varese), Italy; Ambulatorio Veterinario Associato, Torino, Italy; Facoltà di Medicina Veterinaria, Università Degli Studi di Milano, Milano, Italy</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cornegliani, L" sort="Cornegliani, L" uniqKey="Cornegliani L" first="L." last="Cornegliani">L. Cornegliani</name>
<affiliation>
<mods:affiliation>Clinica Veterinaria Malpensa, Samarate (Varese), Italy; Ambulatorio Veterinario Associato, Torino, Italy; Facoltà di Medicina Veterinaria, Università Degli Studi di Milano, Milano, Italy</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Martino, P" sort="Martino, P" uniqKey="Martino P" first="P." last="Martino">P. Martino</name>
<affiliation>
<mods:affiliation>Clinica Veterinaria Malpensa, Samarate (Varese), Italy; Ambulatorio Veterinario Associato, Torino, Italy; Facoltà di Medicina Veterinaria, Università Degli Studi di Milano, Milano, Italy</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Veterinary Dermatology</title>
<title level="j" type="alt">VETERINARY DERMATOLOGY</title>
<idno type="ISSN">0959-4493</idno>
<idno type="eISSN">1365-3164</idno>
<imprint>
<biblScope unit="vol">15</biblScope>
<biblScope unit="page" from="65">65</biblScope>
<biblScope unit="page" to="65">65</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2004-08">2004-08</date>
</imprint>
<idno type="ISSN">0959-4493</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0959-4493</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The objectives of this study were to evaluate in vivo tolerance, and antimicrobial and clinical activities of a topical otic preparation containing EDTA tromethamine (Tris) and chlorhexidine digluconate 0.15% solution (Otodine®) in dogs with chronic bacterial otitis externa. Eleven dogs were included. The affected ears were filled with the solution once daily during a 2‐week period. Dogs were evaluated on days 0, 14 and 28. Three clinical parameters (exudate, erythema, pain) and three cytologic parameters (Malassezia, cocci, rods) were scored (0–4 scale) by otoscopic and cytological examinations of otic exudate. Bacterial cultures were performed at each time point. If there were bacteria on cytological examination on day 14, the dogs were treated with the original product, with the addition of enrofloxacin (5%) applied 10 min after the original product, for a further 2 weeks. All 11 cases yielded isolates of resistant gram‐negative bacteria; gram‐positive bacteria were also isolated from six of 11 dogs. On day 14, six of 11 dogs were negative on culture examination; on day 28, 10 of 11 were negative and only one case had a positive culture. On day 14, clinical and microbial scores (cytology) were reduced by 54.6 and 71.1%, respectively, and by 85.7 and 94% on day 28. All cases reported good tolerance of the treatment. The results show that this ear solution was helpful in the management of chronic bacterial otitis externa in dogs and was well tolerated. There seems to be a synergistic effect of the combination of Tris‐EDTA/chlorhexidine digluconate 0.15% solution, and an antimicrobial agent (enrofloxacin) against resistant gram‐positive and gram‐negative bacteria. Funding: Self‐funded.</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<keywords>
<teeft>
<json:string>dermatitis</json:string>
<json:string>dermatology</json:string>
<json:string>funding</json:string>
<json:string>veterinary medicine</json:string>
<json:string>cutaneous</json:string>
<json:string>veterinary dermatology</json:string>
<json:string>pruritus</json:string>
<json:string>paulo</json:string>
<json:string>esvd</json:string>
<json:string>acvd</json:string>
<json:string>suppl</json:string>
<json:string>atopic</json:string>
<json:string>histopathological</json:string>
<json:string>pyoderma</json:string>
<json:string>nodule</json:string>
<json:string>malassezia</json:string>
<json:string>nantes</json:string>
<json:string>lesion</json:string>
<json:string>clinical signs</json:string>
<json:string>canine</json:string>
<json:string>selamectin</json:string>
<json:string>alopecia</json:string>
<json:string>demodicosis</json:string>
<json:string>poster abstracts</json:string>
<json:string>intermedius</json:string>
<json:string>mite</json:string>
<json:string>universidade</json:string>
<json:string>intradermal</json:string>
<json:string>histological</json:string>
<json:string>psychogenic</json:string>
<json:string>antifungal</json:string>
<json:string>lymphocyte</json:string>
<json:string>atopic dermatitis</json:string>
<json:string>dermatosis</json:string>
<json:string>cytological</json:string>
<json:string>erythema</json:string>
<json:string>prednisolone</json:string>
<json:string>follicle</json:string>
<json:string>ndings</json:string>
<json:string>dermatophytosis</json:string>
<json:string>medicina</json:string>
<json:string>skin scrapings</json:string>
<json:string>skin lesions</json:string>
<json:string>allergy</json:string>
<json:string>pemphigus</json:string>
<json:string>chitosan</json:string>
<json:string>cephalexin</json:string>
<json:string>allergen</json:string>
<json:string>clinique</json:string>
<json:string>histopathological examination</json:string>
<json:string>veterinary</json:string>
<json:string>lufenuron</json:string>
<json:string>pruritic</json:string>
<json:string>lipid</json:string>
<json:string>glucocorticoid</json:string>
<json:string>histopathology</json:string>
<json:string>otitis</json:string>
<json:string>keratinocytes</json:string>
<json:string>cyclosporine</json:string>
<json:string>agar</json:string>
<json:string>canis</json:string>
<json:string>pustule</json:string>
<json:string>papule</json:string>
<json:string>cerumen</json:string>
<json:string>physical examination</json:string>
<json:string>bourdeau</json:string>
<json:string>abnormality</json:string>
<json:string>fungal culture</json:string>
<json:string>fungal</json:string>
<json:string>supplementation</json:string>
<json:string>sebaceous</json:string>
<json:string>histopathologic</json:string>
<json:string>placebo</json:string>
<json:string>dermatological</json:string>
<json:string>staphylococcus</json:string>
<json:string>neutrophilic</json:string>
<json:string>skin biopsies</json:string>
<json:string>veterinary school</json:string>
<json:string>larsson</json:string>
<json:string>pteronyssinus</json:string>
<json:string>farinae</json:string>
<json:string>recurrent pyoderma</json:string>
<json:string>giardia</json:string>
<json:string>exudate</json:string>
<json:string>erythematous</json:string>
<json:string>immunotherapy</json:string>
<json:string>subcutaneous</json:string>
<json:string>epidermal</json:string>
<json:string>psychogenic factors</json:string>
<json:string>ehrlichiosis</json:string>
<json:string>cytologic</json:string>
<json:string>chitosan solution</json:string>
<json:string>felv</json:string>
<json:string>remission</json:string>
<json:string>euthanized</json:string>
<json:string>randomized</json:string>
<json:string>externa</json:string>
<json:string>dermis</json:string>
<json:string>hair coat</json:string>
<json:string>staphylococcus intermedius</json:string>
<json:string>chlorhexidine</json:string>
<json:string>dermal</json:string>
<json:string>sarcoptes</json:string>
<json:string>tumour</json:string>
<json:string>dermatophyte</json:string>
<json:string>guaguere</json:string>
<json:string>lesional</json:string>
<json:string>azithromycin</json:string>
<json:string>lomme</json:string>
<json:string>paulista</json:string>
<json:string>cutaneous lesions</json:string>
<json:string>foliaceus</json:string>
<json:string>cytology</json:string>
<json:string>buenos</json:string>
<json:string>sporotrichosis</json:string>
<json:string>aire</json:string>
<json:string>antibiotic</json:string>
<json:string>canine demodicosis</json:string>
<json:string>laboratoire pathologique</json:string>
<json:string>benzoyl peroxide</json:string>
<json:string>pemphigus foliaceus</json:string>
<json:string>buenos aires</json:string>
<json:string>microscopic examination</json:string>
<json:string>feline</json:string>
<json:string>biopsy</json:string>
<json:string>localized</json:string>
<json:string>case report</json:string>
<json:string>hair follicles</json:string>
<json:string>cytological examination</json:string>
<json:string>side effects</json:string>
<json:string>diabetes mellitus</json:string>
<json:string>canine atopic dermatitis</json:string>
<json:string>sebaceous glands</json:string>
<json:string>healthy dogs</json:string>
<json:string>infestation</json:string>
<json:string>ulcerated</json:string>
<json:string>hind limbs</json:string>
<json:string>otitis externa</json:string>
<json:string>atopic dogs</json:string>
<json:string>royal canin</json:string>
<json:string>universidade estadual paulista</json:string>
<json:string>dermatophagoides farinae</json:string>
<json:string>canine acne</json:string>
<json:string>larsson faculdade</json:string>
<json:string>bovine leukosis virus</json:string>
<json:string>dermatology referral service</json:string>
<json:string>medicina universidade</json:string>
<json:string>tokyo university</json:string>
<json:string>histiocytic sarcoma</json:string>
<json:string>other skin diseases</json:string>
<json:string>hair shafts</json:string>
<json:string>nondegenerative neutrophils</json:string>
<json:string>clinical examination</json:string>
<json:string>poster abstracts topic</json:string>
<json:string>cutaneous epitheliotropic lymphoma</json:string>
<json:string>pastern dermatitis</json:string>
<json:string>sexual status</json:string>
<json:string>intradermal testing</json:string>
<json:string>lymph nodes</json:string>
<json:string>clinical improvement</json:string>
<json:string>parasite</json:string>
<json:string>poster</json:string>
<json:string>carcinoma</json:string>
<json:string>lateral</json:string>
<json:string>cutaneous histiocytoma</json:string>
<json:string>biomedical sciences</json:string>
<json:string>therapeutic trial</json:string>
<json:string>placebo group</json:string>
<json:string>average time</json:string>
<json:string>antibiotic therapy</json:string>
<json:string>fort munro</json:string>
<json:string>medicina veterinaria</json:string>
<json:string>hindlimb paresis</json:string>
<json:string>animal health</json:string>
<json:string>squamous cell carcinoma</json:string>
<json:string>acarus farris</json:string>
<json:string>feline urticaria pigmentosa</json:string>
<json:string>storage mites</json:string>
<json:string>erythema multiforme</json:string>
<json:string>fatty acids</json:string>
<json:string>park college</json:string>
<json:string>universidad nacional</json:string>
<json:string>house dust mites</json:string>
<json:string>complete recovery</json:string>
<json:string>oral cavity</json:string>
<json:string>pemphigus vegetans</json:string>
<json:string>third case</json:string>
<json:string>different phases</json:string>
<json:string>aristotles university</json:string>
<json:string>generalized demodicosis</json:string>
<json:string>poster abstracts treatment</json:string>
<json:string>second case</json:string>
<json:string>feline psychogenic alopecia</json:string>
<json:string>lymphocyte populations</json:string>
<json:string>transmission electron microscopy</json:string>
<json:string>nuclear area</json:string>
<json:string>clinique france</json:string>
<json:string>hovawart dogs</json:string>
<json:string>intradermal tests</json:string>
<json:string>internal diseases</json:string>
<json:string>hair regrowth</json:string>
<json:string>retrospective study</json:string>
<json:string>neotrombicula autumnalis</json:string>
<json:string>sebaceous adenitis</json:string>
<json:string>skin biopsy</json:string>
<json:string>giardia cysts</json:string>
<json:string>nasal planum</json:string>
<json:string>giardia infection</json:string>
<json:string>carpet method</json:string>
<json:string>clinique lomme</json:string>
<json:string>malassezia pachydermatis</json:string>
<json:string>epidemiological features</json:string>
<json:string>toothbrush method</json:string>
<json:string>escola paulista</json:string>
<json:string>nuclear area values</json:string>
<json:string>mast cells</json:string>
<json:string>anal sacs</json:string>
<json:string>localized lesions</json:string>
<json:string>cytologic examination</json:string>
<json:string>antifungal drugs</json:string>
<json:string>agronomical sciences</json:string>
<json:string>susceptibility testing</json:string>
<json:string>vasculitis lesions</json:string>
<json:string>tacrolimus ointment</json:string>
<json:string>feline dermatophytosis</json:string>
<json:string>allergic dermatitis</json:string>
<json:string>days postinoculation</json:string>
<json:string>epidermis</json:string>
<json:string>cat</json:string>
<json:string>nail beds</json:string>
<json:string>epidermal cells</json:string>
<json:string>pathology practice inhisto</json:string>
<json:string>upper dermis</json:string>
<json:string>syncytium formation</json:string>
<json:string>histological diagnosis</json:string>
<json:string>supportive care</json:string>
<json:string>entire body</json:string>
<json:string>histological examination</json:string>
<json:string>alopecic dermatitis</json:string>
<json:string>veterinary science</json:string>
<json:string>skin biopsy specimens</json:string>
<json:string>general anaesthesia</json:string>
<json:string>abdominal pain</json:string>
<json:string>anal sacs myiasis</json:string>
<json:string>lynxacarus radovskyi</json:string>
<json:string>keio university</json:string>
<json:string>lamina lucida</json:string>
<json:string>collagen degeneration</json:string>
<json:string>fungal cultures</json:string>
<json:string>minas gerais</json:string>
<json:string>rhodesian ridgeback dogs</json:string>
<json:string>supraspinous ligament</json:string>
<json:string>clare universidade</json:string>
<json:string>intradermal test</json:string>
<json:string>several species</json:string>
<json:string>complete blood count</json:string>
<json:string>histopathologic evaluation</json:string>
<json:string>dermacentor reticulatus</json:string>
<json:string>melanin clumps</json:string>
<json:string>psychogenic alopecia</json:string>
<json:string>siamese cats</json:string>
<json:string>szent university</json:string>
<json:string>veterinary sciences</json:string>
<json:string>exudate microscopy</json:string>
<json:string>hair pluckings</json:string>
<json:string>pollen allergies</json:string>
<json:string>deep skin scrapings</json:string>
<json:string>sarcoptes scabiei</json:string>
<json:string>grass pollen</json:string>
<json:string>canine patients</json:string>
<json:string>breed predilection</json:string>
<json:string>acarus siro</json:string>
<json:string>lepidoglyphus destructor</json:string>
<json:string>tyrophagus putrescentiae</json:string>
<json:string>house dust</json:string>
<json:string>dermatology clinic</json:string>
<json:string>respiratory signs</json:string>
<json:string>adverse effects</json:string>
<json:string>inhalant therapy</json:string>
<json:string>positive response</json:string>
<json:string>toray industries</json:string>
<json:string>positive intradermal test</json:string>
<json:string>allergy dermatitis</json:string>
<json:string>additional treatment</json:string>
<json:string>adverse events</json:string>
<json:string>histopathological evaluation</json:string>
<json:string>carolina state university</json:string>
<json:string>percentage reduction</json:string>
<json:string>lesional scores</json:string>
<json:string>feline sporotrichosis</json:string>
<json:string>histopathologic examination</json:string>
<json:string>antifungal agent</json:string>
<json:string>various treatments</json:string>
<json:string>malassezia otitis</json:string>
<json:string>dermatological examination</json:string>
<json:string>yellowish material</json:string>
<json:string>morphological changes</json:string>
<json:string>numerous acidophilic acantholytic keratinocytes</json:string>
<json:string>bacterial cultures</json:string>
<json:string>split esculin</json:string>
<json:string>molecular analysis</json:string>
<json:string>acantholytic keratinocytes</json:string>
<json:string>complete remission</json:string>
<json:string>clinical response</json:string>
<json:string>asymptomatic carriers</json:string>
<json:string>lesional biopsies</json:string>
<json:string>histopathological cutaneous lesions</json:string>
<json:string>home environment</json:string>
<json:string>juvenile cellulitis</json:string>
<json:string>veterinary hospital</json:string>
<json:string>domestic cats</json:string>
<json:string>bacterial culture</json:string>
<json:string>lupoid onychodystrophy</json:string>
<json:string>paterson rutland house</json:string>
<json:string>general condition</json:string>
<json:string>miniature schnauzer</json:string>
<json:string>dextrose agar</json:string>
<json:string>asymptomatic carriage</json:string>
<json:string>pruritic skin disease</json:string>
<json:string>faecal samples</json:string>
<json:string>control dogs</json:string>
<json:string>pruritic group</json:string>
<json:string>german shepherd</json:string>
<json:string>monoclonal antibodies</json:string>
<json:string>immune dysregulation</json:string>
<json:string>poor condition</json:string>
<json:string>subcutaneous nodules</json:string>
<json:string>ehrlichia canis</json:string>
<json:string>serum levels</json:string>
<json:string>patent urachus</json:string>
<json:string>blood analysis</json:string>
<json:string>iatrogenic disease</json:string>
<json:string>higher activity</json:string>
<json:string>antibacterial activity</json:string>
<json:string>localized skin lesions</json:string>
<json:string>male german shepherd</json:string>
<json:string>berrocal escuela</json:string>
<json:string>good improvement</json:string>
<json:string>treatment groups</json:string>
<json:string>female dogs</json:string>
<json:string>ionascu faculty</json:string>
<json:string>comparative study</json:string>
<json:string>further investigation</json:string>
<json:string>nuclear areas</json:string>
<json:string>psychogenic treatment</json:string>
<json:string>common disease</json:string>
<json:string>oral pentoxifylline</json:string>
<json:string>food allergy</json:string>
<json:string>skin condition</json:string>
<json:string>elimination diet</json:string>
<json:string>young dogs</json:string>
<json:string>positive culture</json:string>
<json:string>homogeneous population</json:string>
<json:string>cytological smears</json:string>
<json:string>severe pruritus</json:string>
<json:string>clinical data</json:string>
<json:string>poor prognosis</json:string>
<json:string>infrared thermography</json:string>
<json:string>other cases</json:string>
<json:string>skin disease</json:string>
<json:string>hair lipids</json:string>
<json:string>causal category</json:string>
<json:string>histological diagnoses</json:string>
<json:string>skin problems</json:string>
<json:string>dietary lipids</json:string>
<json:string>perianal gland adenoma</json:string>
<json:string>topical cyclosporine</json:string>
<json:string>lipid content</json:string>
<json:string>blood samples</json:string>
<json:string>prostate gland</json:string>
<json:string>feline cutaneous</json:string>
<json:string>cell carcinoma</json:string>
<json:string>chlorhexidine digluconate solution</json:string>
<json:string>original product</json:string>
<json:string>test tubes</json:string>
<json:string>acid concentrations</json:string>
<json:string>colorado state university</json:string>
<json:string>fort collins</json:string>
<json:string>moderate energy</json:string>
<json:string>skin surface</json:string>
<json:string>skin areas</json:string>
<json:string>hair follicle growth arrest</json:string>
<json:string>grass silage</json:string>
<json:string>high energy</json:string>
<json:string>belgian draft horses</json:string>
<json:string>distal limbs</json:string>
<json:string>belgian horses</json:string>
<json:string>pastern region</json:string>
<json:string>skin folds</json:string>
<json:string>chorioptic mange</json:string>
<json:string>equine sarcoidosis</json:string>
<json:string>european laboratory cats</json:string>
<json:string>weight loss</json:string>
<json:string>healthy cattle</json:string>
<json:string>calliper square</json:string>
<json:string>goat warbles</json:string>
<json:string>rohila goats</json:string>
<json:string>little attention</json:string>
<json:string>guinea pigs</json:string>
<json:string>giant cell dermatosis</json:string>
<json:string>mild pruritus</json:string>
<json:string>nile crocodile</json:string>
</teeft>
</keywords>
<author>
<json:item>
<name>G. Ghibaudo</name>
<affiliations>
<json:string>Clinica Veterinaria Malpensa, Samarate (Varese), Italy; Ambulatorio Veterinario Associato, Torino, Italy; Facoltà di Medicina Veterinaria, Università Degli Studi di Milano, Milano, Italy</json:string>
</affiliations>
</json:item>
<json:item>
<name>L. Cornegliani</name>
<affiliations>
<json:string>Clinica Veterinaria Malpensa, Samarate (Varese), Italy; Ambulatorio Veterinario Associato, Torino, Italy; Facoltà di Medicina Veterinaria, Università Degli Studi di Milano, Milano, Italy</json:string>
</affiliations>
</json:item>
<json:item>
<name>P. Martino</name>
<affiliations>
<json:string>Clinica Veterinaria Malpensa, Samarate (Varese), Italy; Ambulatorio Veterinario Associato, Torino, Italy; Facoltà di Medicina Veterinaria, Università Degli Studi di Milano, Milano, Italy</json:string>
</affiliations>
</json:item>
</author>
<articleId>
<json:string>VDE414_74_74</json:string>
</articleId>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>abstract</json:string>
</originalGenre>
<abstract>The objectives of this study were to evaluate in vivo tolerance, and antimicrobial and clinical activities of a topical otic preparation containing EDTA tromethamine (Tris) and chlorhexidine digluconate 0.15% solution (Otodine®) in dogs with chronic bacterial otitis externa. Eleven dogs were included. The affected ears were filled with the solution once daily during a 2‐week period. Dogs were evaluated on days 0, 14 and 28. Three clinical parameters (exudate, erythema, pain) and three cytologic parameters (Malassezia, cocci, rods) were scored (0–4 scale) by otoscopic and cytological examinations of otic exudate. Bacterial cultures were performed at each time point. If there were bacteria on cytological examination on day 14, the dogs were treated with the original product, with the addition of enrofloxacin (5%) applied 10 min after the original product, for a further 2 weeks. All 11 cases yielded isolates of resistant gram‐negative bacteria; gram‐positive bacteria were also isolated from six of 11 dogs. On day 14, six of 11 dogs were negative on culture examination; on day 28, 10 of 11 were negative and only one case had a positive culture. On day 14, clinical and microbial scores (cytology) were reduced by 54.6 and 71.1%, respectively, and by 85.7 and 94% on day 28. All cases reported good tolerance of the treatment. The results show that this ear solution was helpful in the management of chronic bacterial otitis externa in dogs and was well tolerated. There seems to be a synergistic effect of the combination of Tris‐EDTA/chlorhexidine digluconate 0.15% solution, and an antimicrobial agent (enrofloxacin) against resistant gram‐positive and gram‐negative bacteria. Funding: Self‐funded.</abstract>
<qualityIndicators>
<score>8.5</score>
<pdfVersion>1.4</pdfVersion>
<pdfPageSize>595 x 842 pts (A4)</pdfPageSize>
<refBibsNative>false</refBibsNative>
<abstractCharCount>1714</abstractCharCount>
<pdfWordCount>20170</pdfWordCount>
<pdfCharCount>133096</pdfCharCount>
<pdfPageCount>29</pdfPageCount>
<abstractWordCount>261</abstractWordCount>
</qualityIndicators>
<title>P‐74 Evaluation of the in vivo effects of Tris‐EDTA and chlorhexidine digluconate 0.15% solution in chronic bacterial otitis externa: 11 cases</title>
<genre>
<json:string>abstract</json:string>
</genre>
<host>
<title>Veterinary Dermatology</title>
<language>
<json:string>unknown</json:string>
</language>
<doi>
<json:string>10.1111/(ISSN)1365-3164</json:string>
</doi>
<issn>
<json:string>0959-4493</json:string>
</issn>
<eissn>
<json:string>1365-3164</json:string>
</eissn>
<publisherId>
<json:string>VDE</json:string>
</publisherId>
<volume>15</volume>
<pages>
<first>65</first>
<last>65</last>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
</host>
<categories>
<wos>
<json:string>science</json:string>
<json:string>veterinary sciences</json:string>
<json:string>dermatology</json:string>
</wos>
<scienceMetrix>
<json:string>applied sciences</json:string>
<json:string>agriculture, fisheries & forestry</json:string>
<json:string>veterinary sciences</json:string>
</scienceMetrix>
<inist>
<json:string>sciences appliquees, technologies et medecines</json:string>
<json:string>sciences biologiques et medicales</json:string>
<json:string>sciences medicales</json:string>
<json:string>pathologie infectieuse</json:string>
</inist>
</categories>
<publicationDate>2004</publicationDate>
<copyrightDate>2004</copyrightDate>
<doi>
<json:string>10.1111/j.1365-3164.2004.00414_74.x</json:string>
</doi>
<id>3EC2FB89D7D040C56ADD942A27C23D367319F1DA</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/3EC2FB89D7D040C56ADD942A27C23D367319F1DA/fulltext/pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/3EC2FB89D7D040C56ADD942A27C23D367319F1DA/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/3EC2FB89D7D040C56ADD942A27C23D367319F1DA/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main">P‐74 
Evaluation of the
<hi rend="italic">in vivo</hi>
effects of Tris‐EDTA and chlorhexidine digluconate 0.15% solution in chronic bacterial otitis externa: 11 cases</title>
</titleStmt>
<publicationStmt>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2004-08"></date>
</publicationStmt>
<notesStmt>
<note type="content-type" subtype="abstract" source="abstract" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-HPN7T1Q2-R">abstract</note>
<note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc>
<biblStruct type="abstract">
<analytic>
<title level="a" type="main">P‐74 
Evaluation of the
<hi rend="italic">in vivo</hi>
effects of Tris‐EDTA and chlorhexidine digluconate 0.15% solution in chronic bacterial otitis externa: 11 cases</title>
<title level="a" type="short">Poster Abstracts</title>
<author xml:id="author-0000">
<persName>
<forename type="first">G.</forename>
<surname>Ghibaudo</surname>
</persName>
<affiliation>Clinica Veterinaria Malpensa, Samarate (Varese), Italy; Ambulatorio Veterinario Associato, Torino, Italy; Facoltà di Medicina Veterinaria, Università Degli Studi di Milano, Milano, Italy
<address>
<country key="IT"></country>
</address>
</affiliation>
</author>
<author xml:id="author-0001">
<persName>
<forename type="first">L.</forename>
<surname>Cornegliani</surname>
</persName>
<affiliation>Clinica Veterinaria Malpensa, Samarate (Varese), Italy; Ambulatorio Veterinario Associato, Torino, Italy; Facoltà di Medicina Veterinaria, Università Degli Studi di Milano, Milano, Italy
<address>
<country key="IT"></country>
</address>
</affiliation>
</author>
<author xml:id="author-0002">
<persName>
<forename type="first">P.</forename>
<surname>Martino</surname>
</persName>
<affiliation>Clinica Veterinaria Malpensa, Samarate (Varese), Italy; Ambulatorio Veterinario Associato, Torino, Italy; Facoltà di Medicina Veterinaria, Università Degli Studi di Milano, Milano, Italy
<address>
<country key="IT"></country>
</address>
</affiliation>
</author>
<idno type="istex">3EC2FB89D7D040C56ADD942A27C23D367319F1DA</idno>
<idno type="DOI">10.1111/j.1365-3164.2004.00414_74.x</idno>
<idno type="unit">VDE414_74_74</idno>
<idno type="toTypesetVersion">file:VDE.VDE414_74_74.pdf</idno>
</analytic>
<monogr>
<title level="j" type="main">Veterinary Dermatology</title>
<title level="j" type="alt">VETERINARY DERMATOLOGY</title>
<idno type="pISSN">0959-4493</idno>
<idno type="eISSN">1365-3164</idno>
<idno type="book-DOI">10.1111/(ISSN)1365-3164</idno>
<idno type="book-part-DOI">10.1111/vde.2004.15.issue-s1</idno>
<idno type="product">VDE</idno>
<idno type="publisherDivision">ST</idno>
<imprint>
<biblScope unit="vol">15</biblScope>
<biblScope unit="page" from="65">65</biblScope>
<biblScope unit="page" to="65">65</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2004-08"></date>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<abstract xml:lang="en" style="main">
<p>The objectives of this study were to evaluate
<hi rend="italic">in vivo</hi>
tolerance, and antimicrobial and clinical activities of a topical otic preparation containing EDTA tromethamine (Tris) and chlorhexidine digluconate 0.15% solution (Otodine
<hi rend="superscript">®</hi>
) in dogs with chronic bacterial otitis externa. Eleven dogs were included. The affected ears were filled with the solution once daily during a 2‐week period. Dogs were evaluated on days 0, 14 and 28. Three clinical parameters (exudate, erythema, pain) and three cytologic parameters (
<hi rend="italic">Malassezia</hi>
, cocci, rods) were scored (0–4 scale) by otoscopic and cytological examinations of otic exudate. Bacterial cultures were performed at each time point. If there were bacteria on cytological examination on day 14, the dogs were treated with the original product, with the addition of enrofloxacin (5%) applied 10 min after the original product, for a further 2 weeks. All 11 cases yielded isolates of resistant gram‐negative bacteria; gram‐positive bacteria were also isolated from six of 11 dogs. On day 14, six of 11 dogs were negative on culture examination; on day 28, 10 of 11 were negative and only one case had a positive culture. On day 14, clinical and microbial scores (cytology) were reduced by 54.6 and 71.1%, respectively, and by 85.7 and 94% on day 28. All cases reported good tolerance of the treatment. The results show that this ear solution was helpful in the management of chronic bacterial otitis externa in dogs and was well tolerated. There seems to be a synergistic effect of the combination of Tris‐EDTA/chlorhexidine digluconate 0.15% solution, and an antimicrobial agent (enrofloxacin) against resistant gram‐positive and gram‐negative bacteria.</p>
<p>
<hi rend="italic">Funding: Self‐funded.</hi>
</p>
</abstract>
<textClass>
<classCode scheme="tocHeading1">Topic 12: Dermatological therapy</classCode>
</textClass>
<langUsage>
<language ident="EN"></language>
</langUsage>
</profileDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/3EC2FB89D7D040C56ADD942A27C23D367319F1DA/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley component found">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Blackwell Publishing Ltd</publisherName>
<publisherLoc>Oxford, UK</publisherLoc>
</publisherInfo>
<doi origin="wiley" registered="yes">10.1111/(ISSN)1365-3164</doi>
<issn type="print">0959-4493</issn>
<issn type="electronic">1365-3164</issn>
<idGroup>
<id type="product" value="VDE"></id>
<id type="publisherDivision" value="ST"></id>
</idGroup>
<titleGroup>
<title type="main" sort="VETERINARY DERMATOLOGY">Veterinary Dermatology</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="08000">
<doi origin="wiley">10.1111/vde.2004.15.issue-s1</doi>
<numberingGroup>
<numbering type="journalVolume" number="15">15</numbering>
<numbering type="supplement">s1</numbering>
</numberingGroup>
<coverDate startDate="2004-08">August 2004</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="abstract" position="4" status="forIssue">
<doi origin="wiley">10.1111/j.1365-3164.2004.00414_74.x</doi>
<idGroup>
<id type="unit" value="VDE414_74_74"></id>
</idGroup>
<titleGroup>
<title type="tocHeading1">Topic 12: Dermatological therapy</title>
</titleGroup>
<eventGroup>
<event type="firstOnline" date="2004-08-16"></event>
<event type="publishedOnlineFinalForm" date="2004-08-16"></event>
<event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.2 mode:FullText source:Header result:Header" date="2010-03-02"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-10"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-11-04"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst" number="65">65</numbering>
<numbering type="pageLast" number="65">65</numbering>
</numberingGroup>
<linkGroup>
<link type="toTypesetVersion" href="file:VDE.VDE414_74_74.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<titleGroup>
<title type="main">P‐74 
Evaluation of the
<i>in vivo</i>
effects of Tris‐EDTA and chlorhexidine digluconate 0.15% solution in chronic bacterial otitis externa: 11 cases</title>
<title type="short">Poster Abstracts</title>
</titleGroup>
<creators>
<creator creatorRole="author" xml:id="cr1" affiliationRef="#aff-1-1">
<personName>
<givenNames>G.</givenNames>
<familyName>Ghibaudo</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr2" affiliationRef="#aff-1-1">
<personName>
<givenNames>L.</givenNames>
<familyName>Cornegliani</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr3" affiliationRef="#aff-1-1">
<personName>
<givenNames>P.</givenNames>
<familyName>Martino</familyName>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="aff-1-1" countryCode="IT">
<unparsedAffiliation>Clinica Veterinaria Malpensa, Samarate (Varese), Italy; Ambulatorio Veterinario Associato, Torino, Italy; Facoltà di Medicina Veterinaria, Università Degli Studi di Milano, Milano, Italy</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<abstractGroup>
<abstract type="main" xml:lang="en">
<p>The objectives of this study were to evaluate
<i>in vivo</i>
tolerance, and antimicrobial and clinical activities of a topical otic preparation containing EDTA tromethamine (Tris) and chlorhexidine digluconate 0.15% solution (Otodine
<sup>®</sup>
) in dogs with chronic bacterial otitis externa. Eleven dogs were included. The affected ears were filled with the solution once daily during a 2‐week period. Dogs were evaluated on days 0, 14 and 28. Three clinical parameters (exudate, erythema, pain) and three cytologic parameters (
<i>Malassezia</i>
, cocci, rods) were scored (0–4 scale) by otoscopic and cytological examinations of otic exudate. Bacterial cultures were performed at each time point. If there were bacteria on cytological examination on day 14, the dogs were treated with the original product, with the addition of enrofloxacin (5%) applied 10 min after the original product, for a further 2 weeks. All 11 cases yielded isolates of resistant gram‐negative bacteria; gram‐positive bacteria were also isolated from six of 11 dogs. On day 14, six of 11 dogs were negative on culture examination; on day 28, 10 of 11 were negative and only one case had a positive culture. On day 14, clinical and microbial scores (cytology) were reduced by 54.6 and 71.1%, respectively, and by 85.7 and 94% on day 28. All cases reported good tolerance of the treatment. The results show that this ear solution was helpful in the management of chronic bacterial otitis externa in dogs and was well tolerated. There seems to be a synergistic effect of the combination of Tris‐EDTA/chlorhexidine digluconate 0.15% solution, and an antimicrobial agent (enrofloxacin) against resistant gram‐positive and gram‐negative bacteria.</p>
<p>
<i>Funding: Self‐funded.</i>
</p>
</abstract>
</abstractGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>P‐74 Evaluation of the in vivo effects of Tris‐EDTA and chlorhexidine digluconate 0.15% solution in chronic bacterial otitis externa: 11 cases</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>Poster Abstracts</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>P‐74 
Evaluation of the in vivo effects of Tris‐EDTA and chlorhexidine digluconate 0.15% solution in chronic bacterial otitis externa: 11 cases</title>
</titleInfo>
<name type="personal">
<namePart type="given">G.</namePart>
<namePart type="family">Ghibaudo</namePart>
<affiliation>Clinica Veterinaria Malpensa, Samarate (Varese), Italy; Ambulatorio Veterinario Associato, Torino, Italy; Facoltà di Medicina Veterinaria, Università Degli Studi di Milano, Milano, Italy</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">L.</namePart>
<namePart type="family">Cornegliani</namePart>
<affiliation>Clinica Veterinaria Malpensa, Samarate (Varese), Italy; Ambulatorio Veterinario Associato, Torino, Italy; Facoltà di Medicina Veterinaria, Università Degli Studi di Milano, Milano, Italy</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">P.</namePart>
<namePart type="family">Martino</namePart>
<affiliation>Clinica Veterinaria Malpensa, Samarate (Varese), Italy; Ambulatorio Veterinario Associato, Torino, Italy; Facoltà di Medicina Veterinaria, Università Degli Studi di Milano, Milano, Italy</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="abstract" displayLabel="abstract"></genre>
<originInfo>
<publisher>Blackwell Publishing Ltd</publisher>
<place>
<placeTerm type="text">Oxford, UK</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2004-08</dateIssued>
<copyrightDate encoding="w3cdtf">2004</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
</physicalDescription>
<abstract lang="en">The objectives of this study were to evaluate in vivo tolerance, and antimicrobial and clinical activities of a topical otic preparation containing EDTA tromethamine (Tris) and chlorhexidine digluconate 0.15% solution (Otodine®) in dogs with chronic bacterial otitis externa. Eleven dogs were included. The affected ears were filled with the solution once daily during a 2‐week period. Dogs were evaluated on days 0, 14 and 28. Three clinical parameters (exudate, erythema, pain) and three cytologic parameters (Malassezia, cocci, rods) were scored (0–4 scale) by otoscopic and cytological examinations of otic exudate. Bacterial cultures were performed at each time point. If there were bacteria on cytological examination on day 14, the dogs were treated with the original product, with the addition of enrofloxacin (5%) applied 10 min after the original product, for a further 2 weeks. All 11 cases yielded isolates of resistant gram‐negative bacteria; gram‐positive bacteria were also isolated from six of 11 dogs. On day 14, six of 11 dogs were negative on culture examination; on day 28, 10 of 11 were negative and only one case had a positive culture. On day 14, clinical and microbial scores (cytology) were reduced by 54.6 and 71.1%, respectively, and by 85.7 and 94% on day 28. All cases reported good tolerance of the treatment. The results show that this ear solution was helpful in the management of chronic bacterial otitis externa in dogs and was well tolerated. There seems to be a synergistic effect of the combination of Tris‐EDTA/chlorhexidine digluconate 0.15% solution, and an antimicrobial agent (enrofloxacin) against resistant gram‐positive and gram‐negative bacteria. Funding: Self‐funded.</abstract>
<relatedItem type="host">
<titleInfo>
<title>Veterinary Dermatology</title>
</titleInfo>
<genre type="journal">journal</genre>
<identifier type="ISSN">0959-4493</identifier>
<identifier type="eISSN">1365-3164</identifier>
<identifier type="DOI">10.1111/(ISSN)1365-3164</identifier>
<identifier type="PublisherID">VDE</identifier>
<part>
<date>2004</date>
<detail type="volume">
<caption>vol.</caption>
<number>15</number>
</detail>
<detail type="supplement">
<caption>Suppl. no.</caption>
<number>s1</number>
</detail>
<extent unit="pages">
<start>65</start>
<end>65</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">3EC2FB89D7D040C56ADD942A27C23D367319F1DA</identifier>
<identifier type="DOI">10.1111/j.1365-3164.2004.00414_74.x</identifier>
<identifier type="ArticleID">VDE414_74_74</identifier>
<recordInfo>
<recordContentSource>WILEY</recordContentSource>
<recordOrigin>Blackwell Publishing Ltd</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C79 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001C79 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:3EC2FB89D7D040C56ADD942A27C23D367319F1DA
   |texte=   P‐74 Evaluation of the in vivo effects of Tris‐EDTA and chlorhexidine digluconate 0.15% solution in chronic bacterial otitis externa: 11 cases
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024